title: Long term improvement in dyslipidaemia in Type 2 diabetes with bezafibrate is not related to changes in insulin resistance.
authors.forename: R S
authors.initials: RS
authors.lastname: Elkeles
authors.forename: J R
authors.initials: JR
authors.lastname: Diamond
authors.forename: V
authors.initials: V
authors.lastname: Anyaoku
authors.forename: C
authors.initials: C
authors.lastname: Hughes
authors.forename: W
authors.initials: W
authors.lastname: Richmond
mesh_terms: D001629:Bezafibrate / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology*; D005500:Follow-Up Studies; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007333:Insulin Resistance; D008075:Lipoproteins, HDL / Q000187:drug effects; D008077:Lipoproteins, LDL / Q000187:drug effects; D012016:Reference Values; D016896:Treatment Outcome
chemical_list: D000960:Hypolipidemic Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D001629:Bezafibrate